Health company 'Anew' seeks funding from investor 'Qi' in pursuit of a Nasdaq stock exchange listing

In a recent development, Anew Health Ltd., a leading healthcare company, has announced its plans for expansion, both domestically in Hong Kong and internationally. The company, which is preparing for a public listing, has revealed that 30% of the funds raised through the listing will be allocated for setting up a new service centre in Hong Kong, while another 25% will be used to establish centres in other markets.

The expansion plans come at a time when the company's net income has taken a hit. In its latest fiscal year, the net income fell by about half to $5.5 million. This decline, however, seems to be a temporary setback, as the company's growth in other areas suggests a promising future.

Anew Health Ltd.'s expansion has contributed to an increase in general and administrative spending. Additionally, the company's headcount increased by nearly 50% during the most recent fiscal year, with many of the new hires being operation and support personnel to support the expansion.

The company's cost of revenue rose by 16.8% during the same period, growing faster than its revenue. This increase has eroded the gross margin, but the company remains optimistic about its future prospects.

The countries Anew is considering for expansion include Singapore, Malaysia, Japan, South Korea, Canada, and the U.S. However, the search results do not provide information on which Asian countries Anew Health Ltd. has identified as potential locations for expanding their clinics.

The planned expansion is expected to value Anew between $200 million and $300 million, according to the stated price range. With a price-to-sales (P/S) ratio of between 5 and 7.5, the company is poised for significant growth in the coming years.

As Anew Health Ltd. moves forward with its expansion plans, investors and stakeholders will be eager to see how the company navigates these new markets and whether the strategic investments pay off in the long run.

Health company 'Anew' seeks funding from investor 'Qi' in pursuit of a Nasdaq stock exchange listing